FUTURES TOUR GETS NAME SPONSOR

IT'S THE DURAMED FUTURES TOUR NOW!
The Futures Tour – the No 2 women’s professional circuit in the United States – has found itself a name sponsor for the next three years at least.
Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, who produce women’s healthcare products, is a bit of a mouthful to add to the name of a tour so it will go by the name of the Duramed Futures Tour.
Duramed will establish a programme to recognise players who receive exempt LPGA status each year – the top five money-winners at the end of each Futures Tour season - and will put its name on the tour's Player of the Year award.
"It's such a perfect partner for us," said Zayra Calderon, the Futures Tour’s president and chief executive.
"They have such a strong commitment to our mission and they believe in the value of our tour. I'm in seventh heaven."
Calderon would not put a figure on how much money Duramed paid for its title sponsorship, but said the partnership would allow tournament purses to grow at a steady rate and allocate more funds to marketing and promotions.